| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/17/2023 | 10.83% | UBS | $3 → $2.2 | Maintains | Neutral |
| 11/09/2023 | 101.51% | Truist Securities | $5 → $4 | Maintains | Buy |
| 11/09/2023 | 13.35% | RBC Capital | $3.25 → $2.25 | Maintains | Sector Perform |
| 11/09/2023 | 252.64% | Benchmark | $8 → $7 | Maintains | Buy |
| 11/09/2023 | 126.7% | Goldman Sachs | $5 → $4.5 | Maintains | Buy |
| 09/18/2023 | 63.73% | RBC Capital | → $3.25 | Reiterates | Sector Perform → Sector Perform |
| 08/28/2023 | 51.13% | UBS | $3.7 → $3 | Maintains | Neutral |
| 08/23/2023 | 101.51% | Keybanc | $5 → $4 | Maintains | Overweight |
| 08/21/2023 | 151.89% | Truist Securities | → $5 | Reiterates | Buy → Buy |
| 08/10/2023 | 303.02% | Benchmark | $9 → $8 | Maintains | Buy |
| 08/10/2023 | 63.73% | RBC Capital | $3.5 → $3.25 | Maintains | Sector Perform |
| 08/10/2023 | 202.27% | Credit Suisse | $7 → $6 | Maintains | Outperform |
| 08/10/2023 | 56.17% | Citigroup | $3.8 → $3.1 | Maintains | Buy |
| 08/07/2023 | 151.89% | Keybanc | $3 → $5 | Maintains | Overweight |
| 05/30/2023 | 51.13% | Keybanc | → $3 | Reiterates | Overweight → Overweight |
| 05/11/2023 | 76.32% | RBC Capital | → $3.5 | Reiterates | Sector Perform → Sector Perform |
| 05/11/2023 | 252.64% | Credit Suisse | → $7 | Reiterates | Outperform → Outperform |
| 02/15/2023 | 252.64% | Credit Suisse | → $7 | Reiterates | → Outperform |
| 02/15/2023 | 38.54% | UBS | $2 → $2.75 | Upgrades | Sell → Neutral |
| 02/15/2023 | 353.4% | Benchmark | $12 → $9 | Maintains | Buy |
| 02/13/2023 | 71.28% | Citigroup | $2.6 → $3.4 | Maintains | Buy |
| 02/10/2023 | 504.53% | Benchmark | → $12 | Reiterates | → Buy |
| 01/19/2023 | 151.89% | Wells Fargo | $7 → $5 | Maintains | Overweight |
| 12/13/2022 | 30.98% | Citigroup | → $2.6 | Initiates Coverage On | → Buy |
| 12/02/2022 | 0.76% | UBS | → $2 | Initiates Coverage On | → Sell |
| 11/10/2022 | 202.27% | Goldman Sachs | $8.5 → $6 | Maintains | Buy |
| 11/10/2022 | 76.32% | RBC Capital | $6 → $3.5 | Maintains | Sector Perform |
| 11/10/2022 | 252.64% | Credit Suisse | $8 → $7 | Maintains | Outperform |
| 11/10/2022 | 51.13% | Piper Sandler | $5 → $3 | Maintains | Neutral |
| 11/03/2022 | 303.02% | Credit Suisse | $10 → $8 | Maintains | Outperform |
| 08/11/2022 | 403.78% | Credit Suisse | $12 → $10 | Maintains | Outperform |
| 08/11/2022 | 353.4% | Wells Fargo | $11 → $9 | Maintains | Overweight |
| 06/10/2022 | 328.21% | Goldman Sachs | $9 → $8.5 | Maintains | Buy |
| 05/16/2022 | 454.16% | Wells Fargo | $13 → $11 | Maintains | Overweight |
| 05/12/2022 | 353.4% | Goldman Sachs | $12 → $9 | Maintains | Buy |
| 05/11/2022 | 202.27% | RBC Capital | $7 → $6 | Maintains | Sector Perform |
| 05/11/2022 | 151.89% | Piper Sandler | $8 → $5 | Maintains | Neutral |
| 04/11/2022 | 605.29% | Keybanc | $16 → $14 | Maintains | Overweight |
| 02/17/2022 | 554.91% | Credit Suisse | $16 → $13 | Maintains | Outperform |
| 02/17/2022 | 303.02% | Piper Sandler | $12 → $8 | Maintains | Neutral |
| 11/08/2021 | 706.05% | Credit Suisse | $18 → $16 | Maintains | Outperform |
| 11/04/2021 | 706.05% | Keybanc | $18 → $16 | Maintains | Overweight |
| 10/14/2021 | 706.05% | Wells Fargo | $14 → $16 | Maintains | Overweight |
| 08/09/2021 | 605.29% | Wells Fargo | $16 → $14 | Maintains | Overweight |
| 08/06/2021 | 605.29% | RBC Capital | $15 → $14 | Maintains | Sector Perform |
| 08/06/2021 | 655.67% | Oppenheimer | $17 → $15 | Maintains | Outperform |
| 05/27/2021 | 655.67% | RBC Capital | → $15 | Initiates Coverage On | → Sector Perform |
| 02/05/2021 | — | BTIG | Downgrades | Buy → Neutral | |
| 02/01/2021 | 806.8% | Credit Suisse | $17 → $18 | Maintains | Outperform |
| 12/23/2020 | 655.67% | Keybanc | $13 → $15 | Maintains | Overweight |
| 11/09/2020 | 756.42% | Credit Suisse | $19 → $17 | Maintains | Outperform |
| 11/09/2020 | 554.91% | Needham | $15 → $13 | Maintains | Buy |
| 11/09/2020 | 554.91% | Keybanc | $14 → $13 | Maintains | Overweight |
| 11/04/2020 | 605.29% | Keybanc | $15 → $14 | Maintains | Overweight |
| 10/29/2020 | 857.18% | Credit Suisse | → $19 | Initiates Coverage On | → Outperform |
| 10/22/2020 | 655.67% | Needham | $17 → $15 | Maintains | Buy |
| 09/25/2020 | 504.53% | Piper Sandler | → $12 | Initiates Coverage On | → Neutral |
| 09/15/2020 | 655.67% | Keybanc | → $15 | Initiates Coverage On | → Overweight |
| 07/17/2020 | 794.21% | Deutsche Bank | $12.5 → $17.75 | Maintains | Buy |
| 07/17/2020 | 806.8% | Benchmark | $12 → $18 | Maintains | Buy |
| 07/07/2020 | 806.8% | JP Morgan | $11 → $18 | Maintains | Overweight |
| 06/30/2020 | 655.67% | Citigroup | $10 → $15 | Maintains | Buy |
| 06/24/2020 | 756.42% | Needham | $13 → $17 | Maintains | Buy |
| 06/23/2020 | 706.05% | BMO Capital | $10 → $16 | Maintains | Outperform |
| 06/11/2020 | 706.05% | BTIG | → $16 | Initiates Coverage On | → Buy |
| 06/02/2020 | 529.72% | Deutsche Bank | $10 → $12.5 | Maintains | Buy |
| 05/21/2020 | 554.91% | Needham | $11 → $13 | Maintains | Buy |
| 05/11/2020 | 403.78% | Citigroup | $6.5 → $10 | Maintains | Buy |
| 05/08/2020 | 403.78% | UBS | $8 → $10 | Maintains | Buy |
| 05/08/2020 | 454.16% | JP Morgan | $8 → $11 | Maintains | Overweight |
| 05/08/2020 | 454.16% | Needham | $8 → $11 | Maintains | Buy |
| 05/08/2020 | 554.91% | SunTrust Robinson Humphrey | $10 → $13 | Maintains | Buy |
| 04/21/2020 | 303.02% | UBS | $13 → $8 | Maintains | Buy |
| 04/20/2020 | 252.64% | Nomura | $9 → $7 | Maintains | Neutral |
| 04/15/2020 | 403.78% | Wells Fargo | $12 → $10 | Maintains | Overweight |
| 04/08/2020 | 227.46% | Citigroup | $9 → $6.5 | Upgrades | Neutral → Buy |
| 04/07/2020 | 303.02% | Needham | $11 → $8 | Maintains | Buy |
| 03/18/2020 | 353.4% | JP Morgan | $12 → $9 | Maintains | Overweight |
| 02/20/2020 | 504.53% | Aegis Capital | $13 → $12 | Maintains | Buy |
| 02/04/2020 | 504.53% | Benchmark | → $12 | Initiates Coverage On | → Buy |
| 09/17/2019 | 378.59% | Citigroup | → $9.5 | Initiates Coverage On | → Neutral |
| 09/17/2019 | 378.59% | Citigroup | → $9.5 | Initiates Coverage On | → Neutral |
| 09/04/2019 | 504.53% | Raymond James | $22 → $12 | Maintains | Outperform |
| 08/09/2019 | 554.91% | BMO Capital | $20 → $13 | Maintains | Outperform |
| 08/09/2019 | 403.78% | Wedbush | $22 → $10 | Downgrades | Outperform → Neutral |
| 08/09/2019 | 353.4% | Nomura | $17 → $9 | Maintains | Neutral |
| 06/25/2019 | 907.56% | Needham | $23 → $20 | Maintains | Buy |
| 04/29/2019 | 907.56% | JP Morgan | → $20 | Initiates Coverage On | → Overweight |
| 01/08/2019 | 1058.69% | Needham | → $23 | Initiates Coverage On | → Buy |
| 12/19/2018 | 957.93% | SunTrust Robinson Humphrey | → $21 | Initiates Coverage On | → Buy |
| 11/29/2018 | 1915.11% | MKM Partners | $56 → $40 | Maintains | Buy |
| 11/29/2018 | — | Macquarie | Initiates Coverage On | → Outperform |
What is the target price for Angi (ANGI)?
The latest price target for Angi (NASDAQ: ANGI) was reported by UBS on November 17, 2023. The analyst firm set a price target for $2.20 expecting ANGI to rise to within 12 months (a possible 10.83% upside). 25 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Angi (ANGI)?
The latest analyst rating for Angi (NASDAQ: ANGI) was provided by UBS, and Angi maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Angi (ANGI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Angi, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Angi was filed on November 17, 2023 so you should expect the next rating to be made available sometime around November 17, 2024.
Is the Analyst Rating Angi (ANGI) correct?
While ratings are subjective and will change, the latest Angi (ANGI) rating was a maintained with a price target of $3.00 to $2.20. The current price Angi (ANGI) is trading at is $1.99, which is out of the analyst's predicted range.